Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Insmed Incorporated
IM8NCurrent price
66 EUR
0 EUR (0.00%)
Last closed
65 EUR
Company
www.insmed.com
ISIN
US4576693075
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
11 207 807 522 EUR
Yield for 12 month
+166.13 %
1Y
3Y
5Y
10Y
15Y
IM8N
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Address: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
46.7 EURP/E ratio
–Dividend Yield
–Current Year
+275 277 167 EUR
Last Year
+221 296 477 EUR
Current Quarter
+81 480 627 EUR
Last Quarter
+68 095 942 EUR
Current Year
+216 134 714 EUR
Last Year
+171 576 518 EUR
Current Quarter
+62 572 504 EUR
Last Quarter
+52 350 897 EUR
Key Figures IM8N
1 year
3 years
5 years
10 years
EBITDA
-632 221 342 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.77 %
PEG Ratio
–
Return On Equity TTM
-1453.41 %
Wall Street Target Price
46.7 EUR
Revenue TTM
327 194 902 EUR
Book Value
0.23 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
17 %
Dividend Yield
–
Gross Profit TTM
189 415 688 EUR
Earnings per share
-4.85 EUR
Diluted Eps TTM
-4.85 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-244.27 %
Dividend Analytics IM8N
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IM8N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
03.03.2011
Dividend Date
–
Stock Valuation IM8N
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
37.062
Price Sales TTM
34.2542
Enterprise Value EBITDA
-5.7089
Price Book MRQ
322.1727
Financials IM8N
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IM8N
For 52 weeks
19.91 EUR
71.69 EUR
50 Day MA
66.93 EUR
Shares Short Prior Month
–
200 Day MA
39.29 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart